---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-007527"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:24:36.723638+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Two Xenetic directors not standing for re-election at 2024 Annual Meeting

## Summary
- James E. Callaway and Adam Logal will not stand for re-election at the 2024 Annual Meeting of Stockholders.
- Neither director's decision related to any disagreement with the Company on operations, policies or practices.
- The Company thanked both directors for their dedicated Board service.

## SEC filing metadata
- accession: 0001683168-24-007527
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316824007527/0001683168-24-007527-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316824007527/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-007527
- JSON: https://secwatch.observer/filing/0001683168-24-007527.json
- Plain text: https://secwatch.observer/filing/0001683168-24-007527.txt

## Key facts
- Executive change
  Adam Logal departed as member of the board of directors at Xenetic Biosciences, Inc..
  - Action: not stand for re-election
  - Role: member of the board of directors
  source text: On October 29, 2024, James E. Callaway and Adam Logal, each a member of the board of directors (the “Board”) of Xenetic Biosciences, Inc. (the “Company”), informed the Company of their intention to not stand for re-election at the Company’s 2024 Annual Meeting of Stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316824007527/0001683168-24-007527-index.htm
- Executive change
  James E. Callaway departed as member of the board of directors at Xenetic Biosciences, Inc..
  - Action: not stand for re-election
  - Role: member of the board of directors
  source text: On October 29, 2024, James E. Callaway and Adam Logal, each a member of the board of directors (the “Board”) of Xenetic Biosciences, Inc. (the “Company”), informed the Company of their intention to not stand for re-election at the Company’s 2024 Annual Meeting of Stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316824007527/0001683168-24-007527-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.